David Graham
Cardiovascular Disease · Warren, MINPI 1306931068
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.4% of the total across 269 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 12.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,301 and has fallen 92.3% since, to $100 in 2025.
Across 269 payments — averaging $17.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$556
- Novartis$495
- Amgen$431
- Boehringer Ingelheim$404
- Merck$381
- Amarin Pharma, Inc.$334
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,36294%
- Education$2576%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 43 | $556 |
| Novartis | 32 | $495 |
| Amgen | 32 | $431 |
| Boehringer Ingelheim | 23 | $404 |
| Merck | 19 | $381 |
| Amarin Pharma, Inc. | 23 | $334 |
| E.r. Squibb & Sons, L.L.C. | 21 | $334 |
| Esperion Therapeutics, Inc. | 16 | $323 |
| Astellas Pharma US Inc | 3 | $257 |
| Pfizer | 14 | $238 |
| AstraZeneca | 12 | $189 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $161 |
| Novo Nordisk | 8 | $119 |
| Telix Pharmaceuticals | 1 | $100 |
| Boston Scientific | 2 | $47 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Dynavax Technologies Corporation | 1 | $22 |
| Exact Sciences | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Amryt Pharma Holdings Ltd | 1 | $18 |
| Abiomed | 1 | $18 |
| Abbott | 1 | $18 |
| Scpharmaceuticals Inc. | 1 | $16 |
| Edwards Lifesciences | 1 | $15 |
| GSK | 1 | $15 |
| Irhythm Technologies, Inc. | 1 | $14 |
| Bayer | 1 | $13 |
| Medtronic | 1 | $12 |
| Penumbra, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ILLUCCIX$200
How this compares
$4,619 in reported general payments places this provider in the 60th percentile of 760 cardiovascular disease providers in Michigan.
Other cardiovascular disease in Warren
- Theodore SchreiberWarren$72K
- Marschall RungeAnn Arbor$1.8M
- Jihad MustaphaGrand Rapids$1.6M
- Vallerie McLaughlinAnn Arbor$947K
- Pedro Villablanca SpinettoDetroit$620K
- Stanley ChetcutiAnn Arbor$573K
- David HainesRoyal Oak$492K
- Steven AlmanyTroy$471K
- David StroblLansing$445K
- Herman KadoSouthfield$442K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.